第一单位：
Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.;Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
作者：
Victoria,Heredia-Soto [1]
;
Javier,Escudero [2]
;
María,Miguel [2]
;
Patricia,Ruiz [2]
;
Alejandro,Gallego [3]
;
Alberto,Berjón [4]
;
Alicia,Hernández [5]
;
Marta,Martínez-Díez [6]
;
Shuyu,Zheng [7]
;
Jing,Tang [7]
;
David,Hardisson [8]
;
Jaime,Feliu [9]
;
Andrés,Redondo [10]
;
Marta,Mendiola [11]
作者单位：
Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.;Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
[1]
Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
[2]
Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.
[3]
Department of Pathology, Hospital Universitario La Paz, Madrid, Spain.;Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
[4]
Department of Obstetrics and Gynecology, Hospital Universitario La Paz, Madrid, Spain.;Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
[5]
Cell Biology Department, Research and Development, Oncology Business Unit, Pharmamar, Madrid, Spain.
[6]
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
[7]
Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.;Department of Pathology, Hospital Universitario La Paz, Madrid, Spain.;Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.;Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
[8]
Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.;Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.;Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.;Cátedra UAM-ANGEM, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
[9]
Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.;Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.;Cátedra UAM-ANGEM, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
[10]
Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.;Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
[11]
DOI
10.3389/fonc.2022.862321
PMID
35372006
发布时间
2022-04-05
换一批
换一批
